Guido Magni, M.D., Ph.D.


Guido Magni, M.D., Ph.D., is a Partner, having joined Versant in 2012. Guido brings deep experience in drug development from multiple accomplishments at leading global pharmaceutical companies including Roche and Wyeth.


Guido held the position of Global Head of the Medical Science Department at Roche for 12 years and built a track record that includes the approval of 15 new drugs across various therapeutic areas during this time, including blockbuster products Cellcept, Pegasys, Mabthera, Xeloda, Herceptin, Tamiflu and Tarceva. Guido brings this critical expertise to Versant portfolio companies by providing guidance on their clinical and regulatory strategies.